NCT00690287 A Study to Evaluate P-Glucose, Safety and Tolerability After Oral Single Dosing of AZD6370 in Type 2 Diabetic Patients Status COMPLETED Phase PHASE1
NCT00688974 Longitudinal Cohort Study Comparing 2 Surgical Techniques in Patients With Class 3 Obesity and Type 2 Diabetes Status COMPLETED Phase N/A
NCT00688363 Blood Glucose Self Monitoring and HbA1c Effects on Glucose Control Status COMPLETED Phase PHASE4
NCT00683657 Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone Status COMPLETED Phase PHASE3
NCT00682149 Effects of Polyphenol Containing Antioxidants on Oxidative Stress in Diabetic Patients Status UNKNOWN Phase NA
NCT00680745 Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients Status COMPLETED Phase PHASE3
NCT00673231 Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin Status COMPLETED Phase PHASE3
NCT00667732 How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics Status COMPLETED Phase PHASE4
NCT00666458 18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D) Status COMPLETED Phase PHASE3
NCT00661362 Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00660907 Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients Status COMPLETED Phase PHASE3
NCT00659711 The Effect of Januvia (Sitagliptin) on Oxidative Stress in Obese Type 2 Diabetic Subjects Status COMPLETED Phase NA
NCT00658021 Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00654745 18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics Status COMPLETED Phase PHASE4